Chapter 18 Recombinant TRAIL and TRAIL Receptor Analysis

Methods in Enzymology

Volumn 446, Issue , 2008, Pages 293-313

  Harper, Nicholas ^a   MacFarlane, Marion ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CASPASE; CELL SURFACE RECEPTOR; DEATH RECEPTOR; FLUOROCHROME; ISOPROPYL THIOGALACTOSIDE; LIPOCORTIN 5; POLYHISTIDINE TAG; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; ANTIBODY; FLUORESCENT DYE;

ANTINEOPLASTIC ACTIVITY; BACTERIAL STRAIN; BIOTINYLATION; CELL SUSPENSION; ESCHERICHIA COLI; INTERNALIZATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; APOPTOSIS; ARTICLE; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANNEXIN A5; ANTIBODIES; APOPTOSIS; BIOTINYLATION; ESCHERICHIA COLI; FLUORESCENT DYES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 50349096308     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)01618-2     Document Type: Review

References (32)

1. Boldin M.P., Mett I.L., Varfolomeev E.E., Chumakov I., Shemer-Avni Y., Camonis J.H., and Wallach D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270 (1995) 387-391
2. Dyer M.J., MacFarlane M., and Cohen G.M. Barriers to effective TRAIL-targeted therapy of malignancy. J. Clin. Oncol. 25 (2007) 4505-4506
3. Ganten T.M., Haas T.L., Sykora J., Stahl H., Sprick M.R., Fas S.C., Krueger A., Weigand M.A., Grosse-Wilde A., Stremmel W., Krammer P.H., and Walczak H. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ. 11 Suppl 1 (2004) S86-S96
4. Harper N., Farrow S.N., Kaptein A., Cohen G.M., and MacFarlane M. Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases. J. Biol. Chem. 276 (2001) 34743-34752
5. Harper N., Hughes M.A., Farrow S.N., Cohen G.M., and MacFarlane M. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling. J. Biol. Chem. 278 (2003) 44338-44347
6. Inoue S., MacFarlane M., Harper N., Wheat L.M., Dyer M.J., and Cohen G.M. Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies. Cell Death Differ. 11 Suppl 2 (2004) S193-S206
7. Janolino V.G., Fontecha J., and Swaisgood H.E. A spectrophotometric assay for biotin-binding sites of immobilized avidin. Appl. Biochem. Biotech. 56 (1996) 1-7
8. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., and Peter M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14 (1995) 5579-5588
9. Kohlhaas S.L., Craxton A., Sun X.M., Pinkoski M.J., and Cohen G.M. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)induced apoptosis. J. Biol. Chem. 282 (2007) 12831-12841
10. Koschny R., Holland H., Sykora J., Haas T.L., Sprick M.R., Ganten T.M., Krupp W., Bauer M., Ahnert P., Meixensberger J., and Walczak H. Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Clin. Cancer Res. 13 (2007) 3403-3412
11. LeBlanc H.N., and Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10 (2003) 66-75
12. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schutze S., Peter M.E., and Chan A.C. The role of receptor internalization in CD95 signaling. EMBO J. 25 (2006) 1009-10023
13. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998) 491-501
14. MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol. Lett. 139 (2003) 89-97
15. MacFarlane M., Ahmad M., Srinivasula S.M., Fernandes-Alnemri T., Cohen G.M., and Alnemri E.S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272 (1997) 25417-35420
16. MacFarlane M., Cohen G.M., and Dickens M. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: Differential requirements for caspase activation. Biochem. J. 348 Pt 1 (2000) 93-101
17. MacFarlane M., Harper N., Snowden R.T., Dyer M.J., Barnett G.A., Pringle J.H., and Cohen G.M. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 21 (2002) 6809-6818
18. MacFarlane M., Kohlhaas S.L., Sutcliffe M.J., Dyer M.J., and Cohen G.M. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. Cancer Res. 65 (2005) 11265-11270
19. Martin D.A., Siegel R.M., Zheng L., and Lenardo M.J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. J. Biol. Chem. 273 (1998) 4345-4349
20. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., and Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182 (1995) 1545-1556
21. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., and Dixit V.M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273 (1998) 2926-2930
22. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
23. Peter M.E., Hellbardt S., Schwartz-Albiez R., Westendorp M.O., Walczak H., Moldenhauer G., Grell M., and Krammer P.H. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ. 2 (1995) 163-171
24. Peter M.E., and Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10 (2003) 26-35
25. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271 (1996) 12687-12690
26. Savage M.D., Mattson G., Desai S., Nielander G.W., Morgensen S., and Conklin E.J. Avidin-Biotin Chemistry: A Handbook. (1992), Pierce Chemical Co. Product #15055
27. Schneider-Brachert W., Tchikov V., Neumeyer J., Jakob M., Winoto-Morbach S., Held-Feindt J., Heinrich M., Merkel O., Ehrenschwender M., Adam D., Mentlein R., Kabelitz D., and Schutze S. Compartmentalization of TNF receptor 1 signaling: Internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
28. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277 (1997) 818-821
29. Tartaglia L.A., Ayres T.M., Wong G.H., and Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74 (1993) 845-853
30. Varfolomeev E., Maecker H., Sharp D., Lawrence D., Renz M., Vucic D., and Ashkenazi A. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 280 (2005) 40599-40608
31. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
32. Zhang X.D., Franco A.V., Nguyen T., Gray C.P., and Hersey P. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells. J. Immunol. 164 (2000) 3961-3970